Abbisko and Lilly’s Deepening Tie Shows How Oncology’s Real M&A Is Happening in the Shadows
Abbisko Therapeutics expands its Lilly R&D collaboration, revealing how mid-stage oncology biotechs are trading equity upside for pipeline survival...
Abbisko Therapeutics